160 related articles for article (PubMed ID: 7997512)
1. Determination of the radiobiologically hypoxic fraction in multicellular spheroids from data on the uptake of [3H]fluoromisonidazole.
Casciari JJ; Rasey JS
Radiat Res; 1995 Jan; 141(1):28-36. PubMed ID: 7997512
[TBL] [Abstract][Full Text] [Related]
2. Determining hypoxic fraction in a rat glioma by uptake of radiolabeled fluoromisonidazole.
Rasey JS; Casciari JJ; Hofstrand PD; Muzi M; Graham MM; Chin LK
Radiat Res; 2000 Jan; 153(1):84-92. PubMed ID: 10630981
[TBL] [Abstract][Full Text] [Related]
3. Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells.
Rasey JS; Grunbaum Z; Magee S; Nelson NJ; Olive PL; Durand RE; Krohn KA
Radiat Res; 1987 Aug; 111(2):292-304. PubMed ID: 3628717
[TBL] [Abstract][Full Text] [Related]
4. Hypoxic fraction and binding of misonidazole in EMT6/Ed multicellular tumor spheroids.
Franko AJ
Radiat Res; 1985 Jul; 103(1):89-97. PubMed ID: 4070561
[TBL] [Abstract][Full Text] [Related]
5. Growth and radiation sensitivity of the MLS human ovarian carcinoma cell line grown as multicellular spheroids and xenografted tumours.
Rofstad EK; Sutherland RM
Br J Cancer; 1989 Jan; 59(1):28-35. PubMed ID: 2757922
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis, energy metabolism, and fraction of radiobiologically hypoxic cells: a study of human melanoma multicellular spheroids.
Rofstad EK; Eide K; Skøyum R; Hystad ME; Lyng H
Int J Radiat Biol; 1996 Sep; 70(3):241-9. PubMed ID: 8800195
[TBL] [Abstract][Full Text] [Related]
7. Effect of intratumoral heterogeneity in oxygenation status on FMISO PET, autoradiography, and electrode Po2 measurements in murine tumors.
Sørensen M; Horsman MR; Cumming P; Munk OL; Keiding S
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):854-61. PubMed ID: 15936570
[TBL] [Abstract][Full Text] [Related]
8. [18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors.
Sorger D; Patt M; Kumar P; Wiebe LI; Barthel H; Seese A; Dannenberg C; Tannapfel A; Kluge R; Sabri O
Nucl Med Biol; 2003 Apr; 30(3):317-26. PubMed ID: 12745023
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of the binding of labeled fluoromisonidazole in cells in vitro.
Rasey JS; Nelson NJ; Chin L; Evans ML; Grunbaum Z
Radiat Res; 1990 Jun; 122(3):301-8. PubMed ID: 2356284
[TBL] [Abstract][Full Text] [Related]
10. Comparison between the binding of [3H]misonidazole and AF-2 in Chinese hamster V79 spheroids.
Olive PL; Rasey JS; Durand RE
Radiat Res; 1986 Jan; 105(1):105-14. PubMed ID: 3945722
[TBL] [Abstract][Full Text] [Related]
11. Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia.
Rasey JS; Hofstrand PD; Chin LK; Tewson TJ
J Nucl Med; 1999 Jun; 40(6):1072-9. PubMed ID: 10452326
[TBL] [Abstract][Full Text] [Related]
12. A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data.
Casciari JJ; Graham MM; Rasey JS
Med Phys; 1995 Jul; 22(7):1127-39. PubMed ID: 7565388
[TBL] [Abstract][Full Text] [Related]
13. Oxygen enhancement ratio in V79 spheroids.
Durand RE
Radiat Res; 1983 Nov; 96(2):322-34. PubMed ID: 6647761
[TBL] [Abstract][Full Text] [Related]
14. Dependency of the [18F]fluoromisonidazole uptake on oxygen delivery and tissue oxygenation in the porcine liver.
Piert M; Machulla HJ; Becker G; Aldinger P; Winter E; Bares R
Nucl Med Biol; 2000 Nov; 27(8):693-700. PubMed ID: 11150699
[TBL] [Abstract][Full Text] [Related]
15. FMISO accumulation in tumor is dependent on glutathione conjugation capacity in addition to hypoxic state.
Masaki Y; Shimizu Y; Yoshioka T; Nishijima KI; Zhao S; Higashino K; Numata Y; Tamaki N; Kuge Y
Ann Nucl Med; 2017 Oct; 31(8):596-604. PubMed ID: 28695498
[TBL] [Abstract][Full Text] [Related]
16. Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia.
Rasey JS; Koh WJ; Grierson JR; Grunbaum Z; Krohn KA
Int J Radiat Oncol Biol Phys; 1989 Nov; 17(5):985-91. PubMed ID: 2808061
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the distribution of fluorine-18 fluoromisonidazole, deoxyglucose and methionine in tumour tissue.
Kubota K; Tada M; Yamada S; Hori K; Saito S; Iwata R; Sato K; Fukuda H; Ido T
Eur J Nucl Med; 1999 Jul; 26(7):750-7. PubMed ID: 10398823
[TBL] [Abstract][Full Text] [Related]
18. Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids.
Gross MW; Karbach U; Groebe K; Franko AJ; Mueller-Klieser W
Int J Cancer; 1995 May; 61(4):567-73. PubMed ID: 7759162
[TBL] [Abstract][Full Text] [Related]
19. Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. II. RSU 1069.
Olive PL
Br J Cancer; 1995 Mar; 71(3):537-42. PubMed ID: 7880736
[TBL] [Abstract][Full Text] [Related]
20. Influence of heat on the intracellular uptake and radiosensitization of 2-nitroimidazole hypoxic cell sensitizers in vitro.
Brown DM; Cohen MS; Sagerman RH; Gonzalez-Mendez R; Hahn GM; Brown JM
Cancer Res; 1983 Jul; 43(7):3138-42. PubMed ID: 6850622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
